Alerts will be sent to your verified email
Verify EmailNEPHROCARE
|
Nephro Care India
|
Aspira Pathlab&Diagn
|
Invicta Diagnostic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
144.26 % | 5.54 % | 36.05 % |
|
5yr average Equity Multiplier
|
18.06 | 1.42 | 1.54 |
|
5yr Average Asset Turnover Ratio
|
1.28 | 1.0 | 1.21 |
|
5yr Avg Net Profit Margin
|
8.51 % | -3.89 % | 20.01 % |
|
Price to Book
|
1.88 | 7.87 | 0.0 |
|
P/E
|
31.78 | 36.71 | 17.55 |
|
5yr Avg Cash Conversion Cycle
|
-60.13 Days | -26.26 Days | 3155.19 Days |
|
Inventory Days
|
6.87 Days | 10.15 Days | 7.26 Days |
|
Days Receivable
|
13.4 Days | 38.11 Days | 14.01 Days |
|
Days Payable
|
75.6 Days | 81.06 Days | -2240.05 Days |
|
5yr Average Interest Coverage Ratio
|
32.99 | 0.45 | 40.66 |
|
5yr Avg ROCE
|
25.8 % | -0.04 % | 37.62 % |
|
5yr Avg Operating Profit Margin
|
13.74 % | 6.02 % | 37.67 % |
|
5 yr average Debt to Equity
|
10.46 | 0.1 | 0.32 |
|
5yr CAGR Net Profit
|
109.59 % | n/a | 82.73 % |
|
5yr Average Return on Assets
|
12.63 % | -2.37 % | 23.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.71 % | 18.39 % | 66.7 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.33 % | -1.08 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Nephro Care India
|
Aspira Pathlab&Diagn
|
Invicta Diagnostic
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|